ELIZABETH BELMONT: Open Payments
NPI 1447289137 · FREMONT, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$466 in 27 payments from 12 companies in 2025. Trend: 2023 $403 · 2024 $332 · 2025 $466
Food & beverage: $466
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 14 | $221 |
| Viatris Specialty LLC | 2 | $52 |
| Amgen Inc. | 2 | $35 |
| Organon LLC | 1 | $28 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| MEDICEM INC. | 1 | $18 |
| Boston Scientific Corporation | 1 | $16 |
| ABBVIE INC. | 1 | $16 |
| Lilly USA, LLC | 1 | $16 |
Products named: Wegovy, Ozempic, YUPELRI, EVENITY, JARDIANCE, NEXPLANON, TZIELD, DILAPAN-S.
Industry payments across NE — which companies pay providers there.
